Top Markets
Coin of the day
Lifeline Biotechnologies, Inc. Lifeline Biotechnologies, Inc.

Lifeline Biotechnologies, Inc.

LLBO
Rank in Stocks #36501
Lifeline Biotechnologies, Inc. operates as a medical technology company in the... Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
Share Price
$0.0006
Last synced: 2026-08-14
Market Cap
$2.61M
Change (1 day)
50.00%
Change (1 year)
0.00%
Country
US
Trade Lifeline Biotechnologies, Inc. (LLBO)

Category

P/B ratio for Lifeline Biotechnologies, Inc. (LLBO)
P/B ratio as of 2026 TTM: 0
According to Lifeline Biotechnologies, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Lifeline Biotechnologies, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors